Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

A mum lost 6.5st after holiday photos at Disneyland Paris left her feeling “disgusted”. Emily Harris, 31, piled on the pounds ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

It’s possible that by reducing food cravings, they may also reduce cravings for other ... Drug companies Novo Nordisk and Eli ...

A look back at my 2024 predictions is revealing. . Each year I dust off my crystal ball and attempt to divine what lies ahead ...

TIME asked five of the World Economic Forum's Young Global Leaders to share their transformative ideas for 2025. Birgit Skarstein Recently I experienced the remarkable benefits of a self-driving ...

Dr Grant said: “It’s common to feel a little nervous prior to starting Mounjaro. Before people take their first dose, it’s important to read the instructions carefully so they know exactly ...

Why it matters: Lilly's growth prospects are driven by Mounjaro and Zepbound ... head-to-head data for Zepbound over Wegovy, US Food and Drug Administration approval of Zepbound in sleep apnea ...

Lilly’s total revenues for the fourth quarter fell short of expectations due to lower-than-expected sales of its popular GLP-1 drugs, Mounjaro for type II diabetes and Zepbound for obesity.

Once again, the drugmaker reported sales of its blockbuster GLP-1 medicines Zepbound and Mounjaro that missed Wall Street estimates. It was the second consecutive miss for the two closely watched ...

The most prescribed GLP-1 drugs include Ozempic, Wegovy, Mounjaro, CagriSema and Rybelsus. Salty snacks are seeing a slight decline but weren’t on the list of top products experiencing spending ...